Rocket Pharmaceuticals Inc’s filing revealed that its insider Militello John unloaded Company’s shares for reported $19688.0 on Aug 16 ’24. In the deal valued at $18.50 per share,1,064 shares were sold. As a result of this transaction, Militello John now holds 51,451 shares worth roughly $-0.87 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Patel Kinnari sold 3,989 shares, generating $73,812 in total proceeds. Upon selling the shares at $18.50, the insider now owns 396,983 shares.
Before that, Shah Gaurav sold 9,650 shares. Rocket Pharmaceuticals Inc shares valued at $178,564 were divested by the CEO at a price of $18.50 per share. As a result of the transaction, Shah Gaurav now holds 718,419 shares, worth roughly $12.14 million.
Goldman initiated its Rocket Pharmaceuticals Inc [RCKT] rating to a Neutral in a research note published on April 02, 2024; the price target was $39. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late October with a ‘”an Overweight”‘ rating. Morgan Stanley began covering RCKT with “an Overweight” recommendation on February 01, 2023. Canaccord Genuity started covering the stock on November 08, 2022. It rated RCKT as “a Buy”.
Price Performance Review of RCKT
On Monday, Rocket Pharmaceuticals Inc [NASDAQ:RCKT] saw its stock fall -1.23% to $16.90. Over the last five days, the stock has gained 0.78%. Rocket Pharmaceuticals Inc shares have fallen nearly -43.61% since the year began. Nevertheless, the stocks have fallen -3.21% over the past one year. While a 52-week high of $32.53 was reached on 02/27/24, a 52-week low of $15.98 was recorded on 10/03/24. SMA at 50 days reached $18.67, while 200 days put it at $23.60.
Levels Of Support And Resistance For RCKT Stock
The 24-hour chart illustrates a support level at 16.69, which if violated will result in even more drops to 16.48. On the upside, there is a resistance level at 17.27. A further resistance level may holdings at 17.64. The Relative Strength Index (RSI) on the 14-day chart is 42.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.51%. Stochastics %K at 23.30% indicates the stock is a holding.
How much short interest is there in Rocket Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rocket Pharmaceuticals Inc stocks on 2024-09-30, growing by 0.47 million shares to a total of 11.4 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 10.93 million shares. There was a rise of 4.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 01, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $35 price target.
